Viewing Study NCT01068795


Ignite Creation Date: 2025-12-24 @ 1:28 PM
Ignite Modification Date: 2025-12-28 @ 1:09 AM
Study NCT ID: NCT01068795
Status: COMPLETED
Last Update Posted: 2016-02-23
First Post: 2010-01-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome
Sponsor: HaEmek Medical Center, Israel
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module